“Evaluation of the Inhibitory Effect of 2,5-Dimethyl-Celecoxib on Tamoxifen-Sensitive and -Resistant Human Breast Cancer Cells (MCF-7)”. Clinical Medicine and Pharmacology 3, no. 1 (January 31, 2026). Accessed June 16, 2026. https://jandoopress.com/journal/cmp/article/view/215.